Elahere Interactions
There are 146 drugs known to interact with Elahere (mirvetuximab soravtansine), along with 4 disease interactions. Of the total drug interactions, 28 are major, 117 are moderate, and 1 is minor.
- View all 146 medications that may interact with Elahere
- View Elahere disease interactions (4)
Most frequently checked interactions
View interaction reports for Elahere (mirvetuximab soravtansine) and the medicines listed below.
- Allegra Allergy (fexofenadine)
- amlodipine
- aspirin
- carvedilol
- clonidine
- Colace (docusate)
- diazepam
- Doxil (doxorubicin liposomal)
- Enhertu (fam-trastuzumab deruxtecan)
- furosemide
- gabapentin
- Gemzar (gemcitabine)
- glipizide
- hydralazine
- hydrochlorothiazide
- hydrocortisone
- insulin glargine
- Janumet (metformin / sitagliptin)
- Lantus SoloStar (insulin glargine)
- magnesium oxide
- meclizine
- Mekinist (trametinib)
- metformin
- methimazole
- Metoprolol Succinate ER (metoprolol)
- Mounjaro (tirzepatide)
- Mylotarg (gemtuzumab)
- ondansetron
- pantoprazole
- rosuvastatin
Elahere disease interactions
There are 4 disease interactions with Elahere (mirvetuximab soravtansine) which include:
Report options
QR code containing a link to this page
More about Elahere (mirvetuximab soravtansine)
- Elahere consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
